Jazz Pharmaceuticals plc JAZZ
9 insiders sold $49.4M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $49.4M sold on 17 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Bruce C. Cozadd Director |
- | $24.8M | Nov 6, 2026 |
| Robert Iannone EVP, Global Head of R&D & CMO |
- | $19.2M | Aug 27, 2026 |
| Samantha Pearce EVP, Chief Commercial Officer |
- | $1.6M | May 28, 2026 |
| Renee D. Gala President & CEO, Director |
- | $1.2M | Nov 3, 2026 |
| Neena M. Patil EVP & Chief Legal Officer |
- | $850K | Sep 10, 2026 |
| Rick E. Winningham Director |
- | $662K | May 22, 2026 |
| Heather Ann McSharry Director |
- | $482K | May 22, 2026 |
| Patricia Carr SVP, Chief Accounting Officer |
- | $327K | Nov 4, 2026 |
| Mark Douglas Smith Director |
- | $267K | Jun 15, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 28 open-market sales by officers and directors, 2 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Bruce C. Cozadd | Sale | -27,714 | 6.5M |
| Nov 6, 2026 | Bruce C. Cozadd | Sale | -10,688 | 2.5M |
| Nov 6, 2026 | Bruce C. Cozadd | Sale | -24,483 | 5.8M |
| Nov 6, 2026 | Bruce C. Cozadd | Sale | -5,923 | 1.4M |
| Nov 4, 2026 | Patricia Carr | Sale | -1,250 | 289K |
| Nov 4, 2026 | Patricia Carr | Sale | -163 | 38K |
| Nov 3, 2026 | Renee D. Gala | Sale (10b5-1) | -1,000 | 225K |
| Nov 2, 2026 | Bruce C. Cozadd | Sale (10b5-1) | -6,000 | 1.3M |
| Oct 6, 2026 | Renee D. Gala | Sale (10b5-1) | -2,000 | 473K |
| Oct 1, 2026 | Bruce C. Cozadd | Sale (10b5-1) | -6,000 | 1.4M |
| Sep 10, 2026 | Neena M. Patil | Sale (10b5-1) | -1,200 | 289K |
| Sep 8, 2026 | Renee D. Gala | Sale (10b5-1) | -2,000 | 486K |
| Sep 1, 2026 | Bruce C. Cozadd | Sale (10b5-1) | -6,000 | 1.5M |
| Aug 27, 2026 | Robert Iannone | Sale (10b5-1) | -18,187 | 4.5M |
| Aug 27, 2026 | Robert Iannone | Sale (10b5-1) | -11,423 | 2.8M |
| Aug 27, 2026 | Robert Iannone | Sale (10b5-1) | -18,113 | 4.5M |
| Aug 27, 2026 | Robert Iannone | Sale (10b5-1) | -19,639 | 4.9M |
| Aug 27, 2026 | Robert Iannone | Sale (10b5-1) | -9,259 | 2.3M |
| Aug 27, 2026 | Robert Iannone | Sale (10b5-1) | -300 | 76K |
| Aug 3, 2026 | Bruce C. Cozadd | Sale (10b5-1) | -6,000 | 1.5M |
| Jul 1, 2026 | Bruce C. Cozadd | Sale (10b5-1) | -6,000 | 1.4M |
| Jun 15, 2026 | Mark Douglas Smith | Sale (10b5-1) | -1,157 | 267K |
| Jun 10, 2026 | Neena M. Patil | Sale (10b5-1) | -1,200 | 278K |
| Jun 1, 2026 | Bruce C. Cozadd | Sale (10b5-1) | -6,000 | 1.4M |
| May 28, 2026 | Neena M. Patil | Sale (10b5-1) | -1,192 | 282K |
| May 28, 2026 | Samantha Pearce | Sale | -6,907 | 1.6M |
| May 22, 2026 | Rick E. Winningham | Sale | -2,741 | 662K |
| May 22, 2026 | Heather Ann McSharry | Sale | -2,000 | 482K |
Show the other 13 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/JAZZ/export.csv") into a cell.